Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom
CompletedOBSERVATIONAL
Enrollment
28,812
Participants
Timeline
Start Date
January 31, 2000
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Conditions
GlaucomaOcular Hypertension
Interventions
OTHER
no intervention
All Listed Sponsors
lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY
NCT01012245 - Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom | Biotech Hunter | Biotech Hunter